J. Li et al., PRODUCTION AND CONSUMPTION OF THE TETRAPEPTIDE ACSDKP, A NEGATIVE REGULATOR OF HEMATOPOIETIC STEM-CELLS, BY HEMATOPOIETIC MICROENVIRONMENTAL CELLS, Experimental hematology, 25(2), 1997, pp. 140-146
This study was performed to evaluate the role of human microenvironmen
tal cells in the metabolism of AcSDKP, a physiological inhibitor of he
matopoietic stem cells. Using long-term marrow cultures (LTMCs), whose
medium already contained a baseline value of AcSDKP, we found after 2
weeks a net output in the culture supernatant indicating that release
by cells from the adherent layer was superior to consumption of the p
eptide. Since human microenvironmental cells consist of macrophages an
d vascular smooth-muscle-like stromal cells we generated pure populati
ons of macrophages (by culturing cord blood cells in the presence of g
ranulomonocytic colony-stimulating factor) and of stromal cells (gener
ated by stromal colonies). We found in supernatants of macrophage cult
ures a significantly (p < 0.01) increased level of AcSDKP (compared wi
th value in medium) while in supernatants of stromal cell cultures the
level was decreased. Cell content of angiotensin-converting enzyme (A
CE) in stromal cells was higher than in macrophages, which suggests a
degradation of AcSDKP by stromal cells because of their higher amount
of ACE. Finally, we analyzed the content of AcSDKP in adherent layers
of LTMCs (with or without extracellular matrix [ECM] components), macr
ophages, and stromal cells. We found levels of AcSDKP of 1.5 pMol per
10(6) cells in extracts from macrophages or from stromal cells. On the
contrary, extracts from primary layers of LTMCs contained 3 times mor
e AcSDKP; however, after treatment of primary layers by collagenase, A
cSDKP level fell to 1 pMol per 10(6) cells. Immunofluorescence using a
n anti-AcSDKP monoclonal antibody showed an extracellular network in c
ertain areas of LTMCs. This study shows that 1) macrophages synthesize
and release in the supernatant AcSDKP, 2) stromal cells probably degr
ade the peptide via ACE, and 3) components of the ECM from LTMCs serve
as a reservoir for the peptide. These results are reminiscent of what
has been described for growth factors, produced by microenvironmental
cells, and stored in the ECM in close vicinity to hematopoietic precu
rsors.